Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Shares, without par value
-
Shares outstanding
-
193,394,759
-
Total 13F shares
-
17,634,898
-
Share change
-
-1,626,400
-
Total reported value
-
$26,893,042
-
Price per share
-
$1.53
-
Number of holders
-
41
-
Value change
-
-$3,348,567
-
Number of buys
-
14
-
Number of sells
-
35
Institutional Holders of Arbutus Biopharma Corp - Common Shares, without par value (ABUS) as of Q3 2019
As of 30 Sep 2019,
Arbutus Biopharma Corp - Common Shares, without par value (ABUS) was held by
41 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,634,898 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, PRIMECAP MANAGEMENT CO/CA/, LADENBURG THALMANN FINANCIAL SERVICES INC., BANK OF MONTREAL /CAN/, Hudson Bay Capital Management LP, JENNISON ASSOCIATES LLC, BlackRock Inc., SPHERA FUNDS MANAGEMENT LTD., NORGES BANK, and MILLENNIUM MANAGEMENT LLC.
This page lists
42
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.